title: Evaluation of the potential for interactions of paroxetine with diazepam, cimetidine, warfarin, and digoxin.
authors.affiliation: Beecham Laboratories, Product Development, Bristol, Tennessee.
authors.forename: S J
authors.initials: SJ
authors.lastname: Bannister
authors.forename: V P
authors.initials: VP
authors.lastname: Houser
authors.forename: J D
authors.initials: JD
authors.lastname: Hulse
authors.forename: J C
authors.initials: JC
authors.lastname: Kisicki
authors.forename: J G
authors.initials: JG
authors.lastname: Rasmussen
mesh_terms: D000328:Adult; D000928:Antidepressive Agents / Q000493:pharmacokinetics*; D001682:Biological Availability; D002927:Cimetidine / Q000493:pharmacokinetics*; D003975:Diazepam / Q000493:pharmacokinetics*; D004077:Digoxin / Q000493:pharmacokinetics*; D004347:Drug Interactions; D006801:Humans; D008297:Male; D017374:Paroxetine; D010880:Piperidines / Q000493:pharmacokinetics*; D012702:Serotonin Antagonists / Q000493:pharmacokinetics*; D014859:Warfarin / Q000493:pharmacokinetics*
chemical_list: D000928:Antidepressive Agents; D010880:Piperidines; D012702:Serotonin Antagonists; D017374:Paroxetine; D014859:Warfarin; D004077:Digoxin; D002927:Cimetidine; D003975:Diazepam